AC Immune SA
NASDAQ:ACIU
AC Immune SA
NASDAQ:ACIU
Price:
4.62 USD
-4.35%
Updated:
Jun 5, 2024
AC Immune SA
Accounts Receivables
|
AC Immune SA
Accounts Receivables Peer Comparison
Comparables:
ADCT
CRSP
BSLN
IDIA
KURN
Competitive Accounts Receivables Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Accounts Receivables | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
AC Immune SA
NASDAQ:ACIU
|
Accounts Receivables
CHf267k
|
CAGR 3-Years
-27%
|
CAGR 5-Years
-20%
|
CAGR 10-Years
N/A
|
|
|
ADC Therapeutics SA
NYSE:ADCT
|
Accounts Receivables
$25.2m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
163%
|
CAGR 10-Years
N/A
|
|
|
CRISPR Therapeutics AG
NASDAQ:CRSP
|
Accounts Receivables
$0
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Basilea Pharmaceutica AG
SIX:BSLN
|
Accounts Receivables
CHf27.9m
|
CAGR 3-Years
47%
|
CAGR 5-Years
49%
|
CAGR 10-Years
22%
|
|
|
Idorsia Ltd
SIX:IDIA
|
Accounts Receivables
CHf21.5m
|
CAGR 3-Years
68%
|
CAGR 5-Years
59%
|
CAGR 10-Years
N/A
|
|
|
Kuros Biosciences AG
SIX:KURN
|
Accounts Receivables
CHf6.4m
|
CAGR 3-Years
84%
|
CAGR 5-Years
97%
|
CAGR 10-Years
N/A
|
See Also
What is AC Immune SA's Accounts Receivables?
Accounts Receivables
267k
CHF
267k
CHF
Based on the financial report for Mar 31, 2024, AC Immune SA's Accounts Receivables amounts to 267k CHF.
What is AC Immune SA's Accounts Receivables growth rate?
Accounts Receivables CAGR 5Y
-20%
-20%
Over the last year, the Accounts Receivables growth was 34%. The average annual Accounts Receivables growth rates for AC Immune SA have been -27% over the past three years , -20% over the past five years .
You don't have any saved screeners yet
